ARTICLE | Clinical News
Access Pharmaceuticals preclinical data
June 2, 2008 7:00 AM UTC
In animals, IV Cobalamin-targeted polymer-linked dounorubicin reduced tumor volume better than polymer-daunorubicin without the targeting group and daunorubicin alone. Data were presented at the Inter...